Good Jennifer L insider trades
Good Jennifer L has filed 24 Form 4s with the SEC that we hold, for Trevi Therapeutics, Inc. (TRVI) (President & CEO, Director) and Rhythm Pharmaceuticals, INC. (RYTM) (Director). Across all of them we count 0 purchases worth $0 and 11 sales worth $4.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 37,241 shares of Rhythm Pharmaceuticals, INC. worth $1.9M, dated 2024-09-09. The first filing on our record is dated 2022-06-10 and the latest 2026-06-25.
Trevi Therapeutics, Inc. (TRVI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-10 | S, sale reported on Form 4 | 4,578 | $13.3K | 2024-05-14 |
| 2024-05-20 | S, sale reported on Form 4 | 25,037 | $71.6K | 2024-05-22 |
| 2024-09-03 | S, sale reported on Form 4 | 3,863 | $11.7K | 2024-09-05 |
| 2024-09-04 | S, sale reported on Form 4 | 10,981 | $33.2K | 2024-09-05 |
| 2024-09-05 | S, sale reported on Form 4 | 40,277 | $125.3K | 2024-09-05 |
| 2024-09-06 | S, sale reported on Form 4 | 4,219 | $12.8K | 2024-09-09 |
| 2024-09-09 | S, sale reported on Form 4 | 1,840 | $5.6K | 2024-09-09 |
| 2025-03-21 | S, sale reported on Form 4 | 5,263 | $34.6K | 2025-03-25 |
Rhythm Pharmaceuticals, INC. (RYTM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-26 | S, sale reported on Form 4 | 14,508 | $725.5K | 2024-08-28 |
| 2024-09-09 | S, sale reported on Form 4 | 37,241 | $1.9M | 2024-09-11 |
| 2024-09-17 | S, sale reported on Form 4 | 31,751 | $1.7M | 2024-09-19 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1229245) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms